[APLS] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
25-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 157.68%
YoY- 169.13%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 5,650 623 0 250,000 646 0 0 -
PBT -195,571 -219,191 -183,659 80,110 -135,700 -118,617 -168,822 10.29%
Tax 2,165 3,706 5,719 2 9,483 6,914 3,933 -32.80%
NP -195,571 -219,191 -183,659 78,265 -135,700 -118,617 -168,822 10.29%
Tax Rate - - - -0.00% - - - -
Total Cost 201,221 219,814 183,659 171,735 136,346 118,617 168,822 12.40%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -3,461.43 -35,183.15 0.00 31.31 -21,006.19 0.00 0.00 -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -2.28 -2.72 -2.32 0.99 -1.79 -1.57 -2.29 -0.29%
EPS Diluted -2.28 -2.72 -2.32 0.99 -1.79 -1.57 -2.29 -0.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.